Skip to main content
27 November 2024
Last updated:
Monday 25 November 2024
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Stock values decline and companies restructure
Read more
Q4 2022 Stock Comment
Read more
New era for drug pricing in US
Read more
Biotech companies advised to conserve cash
Read more
Antibody-drug conjugates come to the fore
Read more
Stocks plummet in Q2 but biotech keeps innovating
Read more
Biotech values in broad decline
Read more
How a new CNS company was founded, then sold
Read more
Q4 2021 Stock Market Performance
Read more
ESMO 2021: Oncology developers present their findings
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Current page
2
Page
3
Page
4
Page
5
Page
6
Page
7
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
